Article Text

other Versions

PDF
Paper
Beyond antidoping and harm minimisation: a stakeholder-corporate social responsibility approach to drug control for sport
  1. Jason Mazanov
  1. Correspondence to Dr Jason Mazanov, School of Business, UNSW-Canberra, Canberra, ACT 2610, Australia; j.mazanov{at}adfa.edu.au

Abstract

Debate about the ethics of drug control in sport has largely focused on arguing the relative merits of the existing antidoping policy or the adoption of a health-based harm minimisation approach. A number of ethical challenges arising from antidoping have been identified, and a number of, as yet, unanswered questions remain for the maturing ethics of applying harm minimisation principles to drug control for sport. This paper introduces a ‘third approach’ to the debate, examining some implications of applying a stakeholder theory of corporate social responsibility (CSR) to the issue of doping in sport. The introduction of the stakeholder-CSR model creates an opportunity to challenge the two dominant schools by enabling a different perspective to contribute to the development of an ethically robust drug control for sport.

  • Substance Abusers/Users of Controlled Substances
  • Occupational Health

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.